Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Effects of ethanol in a putative rodent model of tardive dyskinesia.

Stoessl AJ.

Pharmacol Biochem Behav. 1996 Jul;54(3):541-6.

PMID:
8743627
3.

Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.

Naidu PS, Kulkarni SK.

Eur J Pharmacol. 2001 Sep 28;428(1):81-6.

PMID:
11779040
4.
5.
6.

Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.

Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM.

Psychopharmacology (Berl). 1996 Oct;127(4):337-45.

PMID:
8923569
7.

Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.

Naidu PS, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 2000 Dec;22(10):747-51.

PMID:
11346896
8.

The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.

Stoessl AJ, Polanski E, Frydryszak H.

Mov Disord. 1993 Oct;8(4):445-52. Review.

PMID:
7901759
9.

Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia.

Van Kampen JM, Stoessl AJ.

Neuroscience. 2000;101(3):629-35.

PMID:
11113312
12.

The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.

Rosengarten H, Bartoszyk GD, Quartermain D, Lin Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):273-9. Epub 2005 Oct 17.

PMID:
16229932
14.

Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.

Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Puntel RL, Paix√£o MW, Braga AL, Calixto JB, Rocha JB, Ferreira J.

Psychopharmacology (Berl). 2007 Oct;194(3):423-32. Epub 2007 Jul 20.

PMID:
17641876
15.
16.

Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.

Singh A, Naidu PS, Kulkarni SK.

Eur J Pharmacol. 2003 Sep 12;477(2):87-94.

PMID:
14519411
17.

Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.

Hashimoto T, Ross DE, Gao XM, Medoff DR, Tamminga CA.

Psychopharmacology (Berl). 1998 May;137(2):107-12.

PMID:
9629996
18.

Effects of neurotensin in a rodent model of tardive dyskinesia.

Stoessl AJ.

Neuropharmacology. 1995 Apr;34(4):457-62.

PMID:
7566478
19.

Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.

Haleem DJ, Samad N, Haleem MA.

Pharmacol Biochem Behav. 2007 May;87(1):115-21. Epub 2007 Apr 13.

PMID:
17498786
20.

Supplemental Content

Support Center